Sign In
Buy VERX
$12.98
+0.600 (+4.85%)
At Close: Jul 13, 2026
Vertex Stock Loses Around $3B in 3 Months: Buy the Dip or Steer Clear?
12:45pm, Wednesday, 11'th Sep 2024
VRTX is a good stock to have in one's portfolio based on its strong overall financial performance and robust pipeline progress.
Vertex to Present at Goldman Sachs Conference
04:05pm, Friday, 06'th Sep 2024
KING OF PRUSSIA, Pa., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that David DeStefano, Chief Executive Officer, and J
Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? I'm Not Convinced
01:00am, Thursday, 05'th Sep 2024
Vertex Pharmaceuticals, a leader in Cystic Fibrosis treatment, reported strong financials in Q2 but faces limited growth in CF due to high market penetration. Despite a GAAP net loss in Q2, Vertex rem
Vertex Completes Acquisition of ecosio
07:05am, Wednesday, 04'th Sep 2024
KING OF PRUSSIA, Pa., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced that it ha
Surging Earnings Estimates Signal Upside for Vertex (VERX) Stock
01:21pm, Tuesday, 03'rd Sep 2024
Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
3 Reasons Why Growth Investors Shouldn't Overlook Vertex (VERX)
01:45pm, Monday, 02'nd Sep 2024
Vertex (VERX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Scoop up These 4 GARP Stocks to Receive Handsome Returns
10:51am, Monday, 02'nd Sep 2024
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. HCA, ADBE, WRB and VERX are some stocks that hold promise.
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
05:50am, Friday, 30'th Aug 2024
Vertex enjoys a monopoly that could soon grow stronger. The company could have multiple potential blockbuster drugs on the way.
Jupiter Endovascular Receives FDA Approval for U.S. Pivotal Study of Vertex Pulmonary Embolectomy System Using Endoportal Control
08:00am, Thursday, 29'th Aug 2024
MENLO PARK, Calif.--(BUSINESS WIRE)-- #FDA--FDA approves U.S. pivotal trial of Jupiter Endovascular pulmonary embolism system with Endoportal Control technology.
Vertex, Inc.: Growth Momentum Continues With FCF Conversion Rates Inflecting Upwards
08:54am, Wednesday, 21'st Aug 2024
Bullish on Vertex, Inc. due to strong growth outlook. 2Q24 results show solid growth across the board, with a strong FCF conversion rate. Ecosio acquisition is accretive, improving product offering, a
Is Vertex (VERX) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Friday, 16'th Aug 2024
Vertex (VERX) could produce exceptional returns because of its solid growth attributes.
3 Stocks to Sell Before the Market Crash Resumes
07:40am, Thursday, 15'th Aug 2024
Markets have yet to recover from the sudden dip they experienced at the start of the month, revealing how poor economic data can spook investors and impact stocks. The drop and rather slow recovery su
The Zacks Analyst Blog Vertex Pharmaceuticals CRISPR and Moderna
05:31am, Friday, 09'th Aug 2024
Vertex Pharmaceuticals CRISPR and Moderna are included in this Analyst Blog.
Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England
07:12pm, Wednesday, 07'th Aug 2024
LONDON--(BUSINESS WIRE)--Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible transfusion-dependent beta thalassemia (TDT) patients to access t
Vertex, Inc. (VERX) Q2 2024 Earnings Call Transcript
12:35pm, Wednesday, 07'th Aug 2024
Vertex, Inc. (NASDAQ:VERX ) Q2 2024 Results Conference Call August 7, 2024 8:30 AM ET Company Participants Joe Crivelli - VP, IR David DeStefano - President and CEO John Schwab - CFO Conference Call P
